Diagnostics and research stocks with the lowest PE ratio
Share price divided by earnings per share over the last twelve months. As of .
- Ranked
- 20
- of 74 diagnostics and research stocks we cover
- Median
- 38.2×
- Lowest
- 24.3×
- LNTH
- Range
- 24.3× to 170×
median 38.2×
24.3×170×
| # | Company | PE | PE vs its 10 years | Revenue growth (TTM) | Market cap |
|---|---|---|---|---|---|
| 1 | LNTHLantheus | 24.3× | 53rd pct | +2.3% | $6.5B |
| 2 | DGXQuest Diagnostics | 24.9× | 98th pct | +9.1% | $27.5B |
| 3 | LHLabcorp | 29.4× | 79th pct | +6.4% | $28.9B |
| 4 | IQVIQVIA | 32.0× | 39th pct | +8.2% | $42.5B |
| 5 | AAgilent Technologies | 34.5× | 56th pct | +8.6% | $49.6B |
| 6 | VCYTVeracyte | 35.0× | 14th pct | +17.3% | $3.9B |
| 7 | CDNACareDx | 35.9× | 97th pct | +38.9% | $4.5B |
| 8 | TMOThermo Fisher Scientific | 36.7× | 68th pct | +8.3% | $256.9B |
| 9 | DHRDanaher | 37.9× | 65th pct | +5.5% | $162.6B |
| 10 | MEDPMedpace | 38.0× | 66th pct | +24.7% | $18.1B |
| 11 | MTDMettler-Toledo International | 38.4× | 57th pct | +6.9% | $34.2B |
| 12 | ILMNIllumina | 44.0× | 31st pct | +4.9% | $35.7B |
| 13 | BIOBio-Rad Laboratories | 44.4× | 54th pct | +1.4% | $9.8B |
| 14 | IDXXIDEXX Laboratories | 46.5× | 20th pct | +12.8% | $52.1B |
| 15 | RVTYRevvity | 72.2× | 90th pct | +4.1% | $16.9B |
| 16 | CAICaris Life Sciences | 86.8× | n/a | +85.4% | $9.1B |
| 17 | NRCNRC Health | 97.0× | 100th pct | −0.2% | $536.6M |
| 18 | WATWaters | 118× | 93rd pct | +52.5% | $46.4B |
| 19 | ICCCImmucell | 132× | 87th pct | +8.5% | $95.9M |
| 20 | BLLNBillionToOne | 170× | n/a | +90.1% | $5.2B |
Not ranked: 49 with a loss over the last year, 1 with a quarter missing, 1 with not a meaningful number. 3 companies whose data behind this number has a caveat are left out until it is checked.
A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.
PE for other groups
Other rankings of diagnostics and research stocks
- Diagnostics and research stocks cheapest against their own PE history
- Diagnostics and research stocks with the lowest price to sales ratio
- Diagnostics and research stocks with the lowest EV/EBIT
- Diagnostics and research stocks with the highest free cash flow yield
- Diagnostics and research stocks with the fastest revenue growth
- Diagnostics and research stocks with the fastest expected revenue growth
- Diagnostics and research stocks with the fastest earnings growth
- Diagnostics and research stocks with the highest profit margins